Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters.
暂无分享,去创建一个
Norbert Lange | R. Guy | N. Lange | R. Lopez | Renata Fonseca Vianna Lopez | M. Bentley | Maria Vitória Lopes Badra Bentley | Richard Guy
[1] R. Panizzon,et al. Photodynamic Therapy of Superficial Basal Cell Carcinomas Using Topical 5-Aminolevulinic Acid in a Nanocolloid Lotion , 1998, Dermatology.
[2] R. Boyle,et al. Photosensitization of pancreatic tumour cells by delta-aminolaevulinic acid esters. , 2000, Anti-cancer drug design.
[3] W. Star,et al. Quantification of Topically Delivered 5-Aminolevulinic Acid by Iontophoresis Across Ex Vivo Human Stratum Corneum¶ , 2002, Photochemistry and photobiology.
[4] M. Hashida,et al. Effects of skin metabolism on percutaneous penetration of lipophilic drugs. , 1997, Journal of pharmaceutical sciences.
[5] J. Hadgraft,et al. Influence of lipophilic counter-ions in combination with phloretin and 6-ketocholestanol on the skin permeation of 5-aminolevulinic acid. , 2003, International journal of pharmaceutics.
[6] S. Jacob,et al. Pharmacology of DMSO. , 1986, Cryobiology.
[7] B. Ortel,et al. Perspectives in cutaneous photodynamic sensitization. , 1996, Journal of photochemistry and photobiology. B, Biology.
[8] J Moan,et al. Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. , 1996, Journal of Photochemistry and Photobiology. B: Biology.
[9] C. Perotti,et al. Topical application of ALA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: tissue distribution , 2003, British Journal of Cancer.
[10] H Kerl,et al. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? , 1993, Journal of the American Academy of Dermatology.
[11] C. Merle,et al. Potential Efficacy of a Delta 5‐Aminolevulinic Acid Bioadhesive Gel Formulation for the Photodynamic Treatment of Lesions of the Gastrointestinal Tract in Mice , 1997, The Journal of pharmacy and pharmacology.
[12] Kristian Berg,et al. 5-Aminolevulinic Acid, but not 5-Aminolevulinic Acid Esters, is Transported into Adenocarcinoma Cells by System BETA Transporters , 2000, Photochemistry and photobiology.
[13] H. Maibach,et al. Topical Drug Bioavailability, Bioequivalence, and Penetration , 1993, Springer US.
[14] H. Wulf,et al. Photodynamic therapy with 5‐aminolevulinic acid in the treatment of actinic cheilitis , 1996, The British journal of dermatology.
[15] S. C. Chang,et al. The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolaevulinic acid administration: an in vivo study. , 1997, Journal of photochemistry and photobiology. B, Biology.
[16] Q. Peng,et al. 5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research , 1997, Photochemistry and photobiology.
[17] R. Guy,et al. Optimization of aminolevulinic acid delivery by iontophoresis. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[18] J. Zachary,et al. Induction of tumor necrosis by delta-aminolevulinic acid and 1,10-phenanthroline photodynamic therapy. , 1996, Cancer research.
[19] Z. Malik,et al. 5-Aminolevulinic acid stimulation of porphyrin and hemoglobin synthesis by uninduced Friend erythroleukemic cells. , 1979, Cell differentiation.
[20] H Fukuda,et al. Tumor-localizing properties of porphyrins. In vitro studies using the porphyrin precursor, aminolevulinic acid, in free and liposome encapsulated forms. , 1989, Drug design and delivery.
[21] D. Kessel,et al. Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid. , 1997, Journal of photochemistry and photobiology. B, Biology.
[22] H Stepp,et al. Photodetection of cervical intraepithelial neoplasia using 5‐aminolevulinic acid–induced porphyrin fluorescence , 2000, Cancer.
[23] R. Guy,et al. Iontophoretic Delivery of 5-Aminolevulinic Acid (ALA): Effect of pH , 2001, Pharmaceutical Research.
[24] Joris Kloek,et al. Derivatives of 5‐Aminolevulinic Acid for Photodynamic Therapy: Enzymatic Conversion into Protoporphyrin , 1998, Photochemistry and photobiology.
[25] H Stepp,et al. Fluorescence staining of laryngeal neoplasms after topical application of 5‐aminolevulinic acid: Preliminary results , 1999, Lasers in surgery and medicine.
[26] J. Moan,et al. Production of protoporphyrin IX from 5-aminolevulinic acid and two of its esters in cells in vitro and tissues in vivo. , 2002, Cellular and Molecular Biology.
[27] A. Lucky,et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. , 2003, Journal of the American Academy of Dermatology.
[28] H. Dailey,et al. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. , 1984, The Biochemical journal.
[29] H. Wulf,et al. Can autofluorescence demarcate basal cell carcinoma from normal skin? A comparison with protoporphyrin IX fluorescence. , 2001, Acta dermato-venereologica.
[30] H Moseley,et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group , 2002, The British journal of dermatology.
[31] P. Schürmann,et al. Inhibition of Escherichia coli porphobilinogen synthase using analogs of postulated intermediates. , 2000, Chemistry & biology.
[32] A. Oseroff,et al. Laser and photodynamic therapy in the management of cutaneous malignancies. , 2001, Clinics in dermatology.
[33] R. Guy,et al. Enhanced Delivery of 5-Aminolevulinic Acid Esters by Iontophoresis In Vitro¶ , 2003, Photochemistry and photobiology.
[34] H. Fukuda,et al. Tumour-localizing properties of porphyrins. In vivo studies using free and liposome encapsulated aminolevulinic acid. , 1992, Comparative biochemistry and physiology. B, Comparative biochemistry.
[35] R. Anderson,et al. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. , 1997, The Journal of investigative dermatology.
[36] H. Hönigsmann,et al. Photodynamic therapy of epithelial skin tumours using delta‐aminolaevulinic acid and desferrioxamine , 1995, The British journal of dermatology.
[37] R. Washbrook,et al. Comparison of delta-aminolaevulinic acid and its methyl ester as an inducer of porphyrin synthesis in cultured cells. , 1997, British Journal of Cancer.
[38] J Moan,et al. DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA , 1995, Photochemistry and photobiology.
[39] L. Leibovici,et al. Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer , 1988, Cancer.
[40] T. Franz,et al. Vehicle effects on percutaneous absorption: in vivo and in vitro comparisons with human skin , 1986, The British journal of dermatology.
[41] T. Redelmeier,et al. Skin Barrier: Principles of Percutaneous Absorption , 1996 .
[42] B. Dixon,et al. Response of a rodent fibrosarcoma to photodynamic therapy using 5-aminolaevulinic acid or polyhaematoporphyrin. , 1995, International journal of radiation biology.
[43] M Korell,et al. Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5‐aminolevulinic acid , 1999, International journal of cancer.
[44] J. Moan,et al. Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester. , 2002, Journal of photochemistry and photobiology. B, Biology.
[45] J. P. Connelly,et al. Comparison of the Pharmacokinetics and Phototoxicity of Protoporphyrin IX Metabolized from 5-Aminolevulinic Acid and Two Derivatives in Human Skin In Vivo¶ , 2000 .
[46] M. Landthaler,et al. Topical 5-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Evaluation of stratum corneum permeability in vitro , 1996 .
[47] A. S. Sobolev,et al. Targeted intracellular delivery of photosensitizers. , 2000, Progress in biophysics and molecular biology.
[48] Joris Kloek,et al. Prodrugs of 5‐Aminolevullinic Acid for Photodynamic Therapy , 1996, Photochemistry and photobiology.
[49] Q. Peng,et al. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. , 2001, Journal of photochemistry and photobiology. B, Biology.
[50] Daniel Braichotte,et al. Clinical Evaluation of the Cutaneous Phototoxicity of 5,10,15,20‐Tetra (m‐hydroxyphenyl)chlorin , 1998, Photochemistry and photobiology.
[51] A. Sarasin,et al. The molecular pathways of ultraviolet-induced carcinogenesis. , 1999, Mutation research.
[52] P. Buettner,et al. Incidence rates of skin cancer in Townsville, Australia , 1998, International journal of cancer.
[53] J. P. Connelly,et al. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose‐controlled delivery of the prodrugs 5‐aminolaevulinic acid and 5‐aminolaevulinic acid‐n‐pentylester , 2001, The British journal of dermatology.
[54] B. Henderson,et al. PHOTOSENSITIZATION OF MURINE TUMOR, VASCULATURE and SKIN BY 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRIN , 1995, Photochemistry and photobiology.
[55] M. Bentley,et al. Photodynamic Therapy of Skin Cancers: Sensitizers, Clinical Studies and Future Directives , 2000, Pharmaceutical Research.
[56] Z. Malik,et al. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. , 1987, British Journal of Cancer.
[57] S. Cohen,et al. Kinetics of transdermal penetration of an organic ion pair: physostigmine salicylate. , 1992, Journal of pharmaceutical sciences.
[58] M. M. el-Sharabasy,et al. Porphyrin metabolism in some malignant diseases. , 1992, British Journal of Cancer.
[59] L. Juillerat-Jeanneret,et al. 5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells. , 2000, Journal of photochemistry and photobiology. B, Biology.
[60] S. Andersson-Engels,et al. Photodynamic therapy using intravenous delta-aminolaevulinic acid-induced protoporphyrin IX sensitisation in experimental hepatic tumours in rats. , 1996, British Journal of Cancer.
[61] J. M. Marchetti,et al. A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[62] A. Porwit,et al. Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response. , 2001, Acta dermato-venereologica.
[63] T. Ruzicka,et al. Photodynamic therapy in dermatology. , 1998, Archives of dermatology.
[64] Petras Juzenas,et al. Topical Application of 5-Aminolevulinic Acid and its Methylester, Hexylester and Octylester Derivatives: Considerations for Dosimetry in Mouse Skin Model¶ , 2002, Photochemistry and photobiology.
[65] J. Nelson,et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. , 1997, Archives of dermatology.
[66] L. Juillerat-Jeanneret,et al. Ethylene glycol and amino acid derivatives of 5-aminolevulinic acid as new photosensitizing precursors of protoporphyrin IX in cells. , 2000, Journal of medicinal chemistry.
[67] Stanley B. Brown,et al. 5-Aminolaevulinic Acid Methyl Ester Transport on Amino Acid Carriers in a Human Colon Adenocarcinoma Cell Line¶ , 2001, Photochemistry and photobiology.
[68] J C Kennedy,et al. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.
[69] A. Oseroff,et al. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. , 2003, Molecular immunology.
[70] P Lehmann,et al. Preferential Relative Porphyrin Enrichment in Solar Keratoses upon Topical Application of ^‐Aminolevulinic Acid Methylester , 1998, Photochemistry and photobiology.
[71] J. Kennedy,et al. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.
[72] H Stepp,et al. Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. , 1996, Journal of photochemistry and photobiology. B, Biology.
[73] H. Mukhtar,et al. Photodynamic therapy in dermatology. , 2000, Journal of the American Academy of Dermatology.
[74] L. O. Svaasand,et al. Light and drug distribution with topically administered photosensitizers , 1996, Lasers in Medical Science.
[75] Johan Moan,et al. Topical Application of 5-Aminolevulinic Acid Hexyl Ester and 5-Aminolevulinic Acid to Normal Nude Mouse Skin: Differences in Protoporphyrin IX Fluorescence Kinetics and the Role of the Stratum Corneum¶ , 2000, Photochemistry and photobiology.
[76] J Moan,et al. 5‐Aminolevulinic acid‐based photodynamic therapy , 1997, Cancer.
[77] D. Vernon,et al. Porphyrin accumulation induced by 5-aminolaevulinic acid esters in tumour cells growing in vitro and in vivo , 2002, British Journal of Cancer.
[78] H Anholt,et al. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. , 1997, Cancer research.
[79] Willem M. Star,et al. Protoporphyrin IX Fluorescence Kinetics and Localization after Topical Application of ALA Pentyl Ester and ALA on Hairless Mouse Skin with UVB-Induced Early Skin Cancer , 2000, Photochemistry and photobiology.
[80] Rudolf M. Huber,et al. 5-Aminolaevulinic Acid (ALA) for the Fluorescence Detection of Bronchial Tumors , 1999, Diagnostic and therapeutic endoscopy.
[81] M. Landthaler,et al. The Use of Photodynamic Therapy for Skin Cancer , 1998, Oncology Research and Treatment.
[82] K. Berg,et al. The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells. , 1996, British Journal of Cancer.
[83] H. Bergh,et al. Routine experimental system for defining conditions used in photodynamic therapy and fluorescence photodetection of (non-) neoplastic epithelia. , 2001, Journal of biomedical optics.
[84] S. Eksborg,et al. Stability of 5-aminolevulinic acid in aqueous solution. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[85] C. Perotti,et al. ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitization , 2001, British Journal of Cancer.
[86] T. Ghosh,et al. Iontophoresis and electroporation: comparisons and contrasts. , 1999, International journal of pharmaceutics.
[87] T J Dougherty,et al. Photodynamic therapy--new approaches. , 1989, Seminars in surgical oncology.
[88] K Svanberg,et al. Photodynamic therapy of non‐melanoma malignant tumours of the skin using topical δ‐amino levulinic acid sensitization and laser irradiation , 1994, The British journal of dermatology.
[89] Geoffrey Lee,et al. Self-adhesive thin films for topical delivery of 5-aminolevulinic acid. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[90] L. Juillerat-Jeanneret,et al. Evaluation of dipeptide-derivatives of 5-aminolevulinic acid as precursors for photosensitizers in photodynamic therapy. , 2003, Bioorganic & medicinal chemistry.
[91] M. Landthaler,et al. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. , 1996, Dermatology.
[92] Robert L. Bronaugh. Diffusion Cell Design , 1993 .
[93] G. B. V. Beijersbergen van Henegouwen,et al. In Vitro Fluorescence, Toxicity and Phototoxicity Induced by δ-Aminolevulinic Acid (ALA) or ALA-Esters , 2000, Photochemistry and photobiology.
[94] G. Fabbrocini,et al. Photodynamic therapy with topical δ-aminolaevulinic acid for the treatment of plantar warts , 2001 .
[95] Z. Malik,et al. Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice. , 1995, Journal of photochemistry and photobiology. B, Biology.
[96] G. D. Di Venosa,et al. The influence of the vehicle on the synthesis of porphyrins after topical application of 5‐aminolaevulinic acid. Implications in cutaneous photodynamic sensitization , 2000, The British journal of dermatology.
[97] S. Arkins,et al. PHOTODESTRUCTION OF TUMOR CELLS BY INDUCTION OF ENDOGENOUS ACCUMULATION OF PROTOPORPHYRIN IX: ENHANCEMENT BY 1, 10‐PHENANTHROLINE , 1992, Photochemistry and photobiology.
[98] M W Berns,et al. Dosimetry model for photodynamic therapy with topically administered photosensitizers , 1996, Lasers in surgery and medicine.
[99] H. Soyer,et al. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. , 1998, Archives of dermatology.
[100] D. Shemin,et al. Delta-aminolevulinic acid dehydratase of Rhodopseudomonas spheroides. II. Association to polymers and dissociation to subunits. , 1968, The Journal of biological chemistry.
[101] J. M. Marchetti,et al. In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[102] P Lehmann,et al. Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of δ-aminolaevulinic acid , 1999, British Journal of Cancer.
[103] H. Dailey,et al. Multiple mechanisms for the regulation of haem synthesis during erythroid cell differentiation. Possible role for coproporphyrinogen oxidase. , 1991, The Biochemical journal.
[104] A. Curnow,et al. Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents. , 1998, British Journal of Cancer.
[105] H. Kerl,et al. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. , 1994, Journal of the American Academy of Dermatology.
[106] A. Tedesco,et al. Cubic phase gel as a drug delivery system for topical application of 5-ALA, its ester derivatives and m-THPC in photodynamic therapy (PDT). , 2003, Journal of photochemistry and photobiology. B, Biology.
[107] C. Perotti,et al. ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumour organ cultures , 2002, British Journal of Cancer.
[108] F. Döring,et al. Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. , 1998, The Journal of clinical investigation.
[109] M. Alpsten,et al. Treatment of superficial basal cell carcinomas using topically applied delta-aminolaevulinic acid and a filtered xenon lamp , 1996, Archives of Dermatological Research.
[110] Bruce J. Tromberg,et al. ALA- and ALA-ester-mediated Photodynamic Therapy of Human Glioma Spheroids , 2002, Journal of Neuro-Oncology.
[111] R. Westendorp,et al. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. , 1998, The Journal of investigative dermatology.
[112] N. Navone,et al. Heme biosynthesis in human breast cancer--mimetic "in vitro" studies and some heme enzymic activity levels. , 1990, The International journal of biochemistry.
[113] R. Gurny,et al. State of the art in the delivery of photosensitizers for photodynamic therapy. , 2002, Journal of photochemistry and photobiology. B, Biology.
[114] A. Richardson,et al. NUTRITION INVESTIGATIONS UPON COTTONSEED MEAL. II , 1916 .
[115] H. Nakanishi,et al. Synthesis and biological studies of 5-aminolevulinic acid-containing dendrimers for photodynamic therapy. , 2001, Bioconjugate chemistry.
[116] R. Anderson,et al. Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: a clinical and histologic study. , 1995, Archives of dermatology.
[117] L. Guillou,et al. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. , 2003, The Journal of urology.
[118] B. Hirshowitz,et al. Modified Topical Photodynamic Therapy of Superficial Skin Tumors, Utilizing Aminolevulinic Acid, Penetration Enhancers, Red Light, and Hypertherntia , 1998, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[119] K. König,et al. Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo , 2004, Archives of Dermatological Research.
[120] P. Calzavara-Pinton,et al. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. , 1995, Journal of photochemistry and photobiology. B, Biology.
[121] A. MacRobert,et al. Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures , 1999, British Journal of Cancer.
[122] J. Moan,et al. Photodynamic Therapy of Superficial Basal Cell Carcinoma with 5-Aminolevulinic Acid with Dimethylsulfoxide and Ethylendiaminetetraacetic Acid: A Comparison of Two Light Sources , 2000, Photochemistry and photobiology.
[123] M. Mycek,et al. Handbook of Biomedical Fluorescence , 2003 .
[124] R. Knuechel,et al. The Effects of 5-Aminolevulinic Acid Esters on Protoporphyrin IX Production in Human Adenocarcinoma Cell Lines¶ , 2001 .
[125] L. Guillou,et al. Fluorescence Photodetection (pd) and Photodynamic Therapy Photodetection of Early Human Bladder Cancer Based on the Fluorescence of 5-aminolaevulinic Acid Hexylester- Induced Protoporphyrin Ix: a Pilot Study , 2022 .